Related Experiment Video
Updated: Mar 21, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Severe Congenital Protein C Deficiency: Practical Aspects of Management
Ravi Shah1, Patrick Ferreira2, Shelina Karmali1
1Pediatric Hematology, Alberta Children's Hospital, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Insights
Subcutaneous protein C (PC) therapy effectively managed purpura fulminans in a child with congenital PC deficiency for over three years. Home-based SC PC replacement proved safe and successful, monitored by PC activity and D-dimer levels.
Area of Science:
- Biochemistry
- Hematology
- Pediatric Thrombosis
Background:
- Severe congenital protein C (PC) deficiency can lead to life-threatening purpura fulminans.
- Effective long-term management strategies for pediatric PC deficiency are crucial.
Observation:
- A child with purpura fulminans secondary to severe congenital PC deficiency was treated with subcutaneous (SC) protein C (PC).
- Home therapy involved SC PC administration (80-120 IU/kg over 60-90 min every 48 hours) for over three years.
- Treatment monitoring included trough PC chromogenic activity (target ≥15%) and D-dimer levels.
Findings:
- SC PC home therapy was successful for over three years in maintaining clinical stability.
- Discontinuation of enoxaparin did not alter the clinical course, suggesting PC replacement alone was sufficient.
- A notable discrepancy was observed between clotting-based and chromogenic-based PC activity measurements.
Implications:
- Subcutaneous protein C replacement is a viable and effective long-term home therapy for severe congenital PC deficiency in children.
- This approach offers a practical alternative to intravenous administration, improving patient quality of life.
- Further investigation into the discrepancy between different PC activity assays is warranted for accurate therapeutic monitoring.
Abstract:
Subcutaneous (SC) protein C (PC) was used in a child with purpura fulminans secondary to severe congenital PC deficiency. For maintenance, PC 80-120 IU/kg, given over 60-90 min SC Q48hr, has been successful as a home therapy for more than 3 years. The treatment was monitored by measuring trough PC chromogenic activity (target ≥15%) and D-dimer levels. No change in clinical course was appreciated after discontinuing enoxaparin (and leaving the patient on prophylactic PC replacement alone). A significant discrepancy between clotting-based and chromogenic-based PC activity is shown.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Venous Thrombosis III: Interprofessional Care
Cytomegalovirus Disease
Nephrotic Syndrome III : Nursing Management
Cardiomyopathy V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care

